All 1 tracked stories fall under one category: health-it. AstraZeneca is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 7 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Assertio
All 1 tracked stories fall under one category: health-it. AstraZeneca is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 7 original sources each against 3.1 for the same window. Their average consequence score of 5 runs below the beat's 6.3 for that window. We currently track 1 Healthcare story that mention Assertio, all published on March 17, 2026.
Stories tracked
1
Sources per story
7
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Assertio. Shared-story counts are live from our verified record — not editorial picks.
DocGo is successfully transitioning from large-scale government contracts to high-growth remote patient monitoring and mobile health services, while specialty firms like Kyntra Bio and Assertio are streamlining operations to focus on core clinical assets. These shifts reflect a broader industry trend toward sustainable, technology-driven care models and disciplined capital allocation.
Assertio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.